Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Real-world outcomes for anti-CD38 monoclonal antibody-naive and exposed patients receiving treatment for multiple myeloma

Benjamin Derman, Magnolia Watson, Jacob Ambrose, Christina Zettler, Andrew Belli, Laura Fernandes, Ming He

Blood (2025) 146 (Supplement 1): 2795.

https://doi.org/10.1182/blood-2025-2795

Published: 2025

Journal Articles

Analysis of real-world overall survival (rwOS) among patients with third-line or later (3L+) diffuse large B-cell lymphoma (DLBCL) with multiple qualifying index dates treated in the United States

Michael Wallington, Yong Chen, Fei Jie, Monica Patterson, Karen Repetny, Michelle Fanale, Simon Purcell, Jacob Ambrose, Christina Zettler, Andrew Belli, Laura L. Fernandes, Ching-Kun Wang

Blood (2025) 146 (Supplement 1): 4511.

https://doi.org/10.1182/blood-2025-4511

Published: 2025

Journal Articles

Real-world clinical characteristics and outcomes of patients with myelodysplastic syndrome with TP53 mutation

Diego Adrianzen Herrera, Jacob Ambrose, Andrew Belli, Eric Hansen, Christina Zettler, Laura Fernandes, Ming He, Stephanie Wiley, Ching-Kun Wang

Blood (2025) 146 (Supplement 1): 4606.

https://doi.org/10.1182/blood-2025-4606

Published: 2025

Journal Articles

Real-world treatment patterns and outcomes of patients with myelodysplastic syndrome by line of therapy

Diego Adrianzen Herrera, Jacob Ambrose, Andrew Belli, Eric Hansen, Christina Zettler, Laura Fernandes, Stephanie Wiley, Courtney Anderson, Ching-Kun Wang

Blood (2025) 146 (Supplement 1): 601.

https://doi.org/10.1182/blood-2025-601

Published: 2025

Journal Articles

R-mini-CHOP preserves efficacy and limits toxicity for patients ≥ 80 years old with DLBCL

Danielle Wallace, Claire Bai, Andrew Belli, Eric Hansen, Christina Zettler, Laura Fernandes, Stephanie Wiley, Ching-Kun Wang, Paul Barr

Blood (2025) 146 (Supplement 1): 6277.

https://doi.org/10.1182/blood-2025-6277

Published: 2025

Update search

NARROW

Publications

Format

Article Type

Date

Availability

Real-world outcomes for anti-CD38 monoclonal antibody-naive and exposed patients receiving treatment for multiple myeloma

Analysis of real-world overall survival (rwOS) among patients with third-line or later (3L+) diffuse large B-cell lymphoma (DLBCL) with multiple qualifying index dates treated in the United States

Real-world clinical characteristics and outcomes of patients with myelodysplastic syndrome with TP53 mutation

Real-world treatment patterns and outcomes of patients with myelodysplastic syndrome by line of therapy

R-mini-CHOP preserves efficacy and limits toxicity for patients ≥ 80 years old with DLBCL

Email alerts

ASH Publications

American Society of Hematology

Update search

Real-world outcomes for anti-CD38 monoclonal antibody-naive and exposed patients receiving treatment for multiple myeloma

Analysis of real-world overall survival (rwOS) among patients with third-line or later (3L+) diffuse large B-cell lymphoma (DLBCL) with multiple qualifying index dates treated in the United States

Real-world clinical characteristics and outcomes of patients with myelodysplastic syndrome with TP53 mutation

Real-world treatment patterns and outcomes of patients with myelodysplastic syndrome by line of therapy

R-mini-CHOP preserves efficacy and limits toxicity for patients ≥ 80 years old with DLBCL

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only